{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:19:16Z","timestamp":1778617156153,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T00:00:00Z","timestamp":1447891200000},"content-version":"vor","delay-in-days":444,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1038\/ki.2014.58","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T13:45:01Z","timestamp":1395236701000},"page":"638-647","source":"Crossref","is-referenced-by-count":162,"title":["A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients"],"prefix":"10.1016","volume":"86","author":[{"given":"J\u00fcrgen","family":"Floege","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian C.","family":"Covic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ketteler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjay","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.F.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Lisk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart M.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2014.58_bb0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.ackd.2011.01.001","article-title":"The roles of the skeleton and phosphorus in the CKD mineral bone disorder","volume":"18","author":"Hruska","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1038\/ki.2014.58_bb0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00041552-200111000-00003","article-title":"Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis)","volume":"10","author":"Block","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.2014.58_bb0020","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.58_bb0025","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"10.1038\/ki.2014.58_bb0030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000197562","article-title":"Phosphate\u2014the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review","volume":"27","author":"Kanbay","year":"2009","journal-title":"Blood Purif"},{"key":"10.1038\/ki.2014.58_bb0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.58_bb0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.58_bb0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2011.12.025","article-title":"Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Evaluation of Possible Confounding by Nutritional Status","volume":"60","author":"Lopes","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.58_bb0050","first-page":"525","article-title":"Challenge of phosphorus control in hemodialysis patients: a problem of adherence?","volume":"23","author":"Arenas","year":"2010","journal-title":"J Nephrol"},{"key":"10.1038\/ki.2014.58_bb0055","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.58_bb0060","series-title":"Abstract presented at the European Renal Association\u2014European Dialysis and Transplantation Association Annual Meeting","first-page":"24","article-title":"Pill burden and its Association with Medication Possession Ratio Among Hemodialysis Patients with Hyperphosphatemia","author":"Wang","year":"2012"},{"key":"10.1038\/ki.2014.58_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5414\/CNP74004","article-title":"PA21: a novel phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease","volume":"74","author":"Geisser","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2014.58_bb0070","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/ndt\/14.4.863","article-title":"Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients","volume":"14","author":"Hergesell","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2014.58_bb0075","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2215\/CJN.08230811","article-title":"Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients","volume":"8","author":"Wuthrich","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.58_bb0080","first-page":"793A","article-title":"Self-reported non-adherence with phosphate binder prescription is associated with high serum phosphorus and PTH: results from the DOPPS [abstract]","volume":"23","author":"Tentori","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.58_bb0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2369-9-2","article-title":"A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease","volume":"9","author":"Karamanidou","year":"2008","journal-title":"BMC Nephrol"},{"key":"10.1038\/ki.2014.58_bb0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4037\/ajcc2007.16.3.222","article-title":"Prevalence and consequences of nonadherence to hemodialysis regimens","volume":"16","author":"Denhaerynck","year":"2007","journal-title":"Am J Crit Care"},{"key":"10.1038\/ki.2014.58_bb0095","series-title":"Abstract presented at the 49th Annual Meeting of the European Renal Association\u2014European Dialysis and Transplantation Association","first-page":"24","article-title":"Pill Burden and its Association with Medication Possession Ratio Among Hemodialysis Patients with Hyperphosphatemia","author":"Bond","year":"2012"},{"key":"10.1038\/ki.2014.58_bb0100","first-page":"793A","article-title":"Reasons for phosphate binder discontinuation vary by binder type [Abstract]","volume":"23","author":"Alfieri","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.58_bb0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.ackd.2006.10.001","article-title":"The prevalence of symptoms in end-stage renal disease: a systematic review","volume":"14","author":"Murtagh","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1038\/ki.2014.58_bb0110","series-title":"Prescribing Information","author":"Renvela\u00ae (sevelamer carbonate)","year":"2011"},{"key":"10.1038\/ki.2014.58_bb0115","doi-asserted-by":"crossref","first-page":"c25","DOI":"10.1159\/000341922","article-title":"The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients","volume":"121","author":"Sinsakul","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/ki.2014.58_bb0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.ajkd.2012.04.001","article-title":"The DOPPS Practice Monitor for US dialysis care: trends through August 2011","volume":"60","author":"Pisoni","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.58_bb0125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1053\/j.ajkd.2012.11.041","article-title":"Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial","volume":"61","author":"Dwyer","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.58_bb0130","doi-asserted-by":"crossref","first-page":"c25","DOI":"10.1159\/000341922","article-title":"The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients","volume":"121","author":"Sinsakul","year":"2012","journal-title":"Nephron Clin Pract"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815303197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815303197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T13:39:53Z","timestamp":1597585193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815303197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0085253815303197"],"URL":"https:\/\/doi.org\/10.1038\/ki.2014.58","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}